Kayu Manis Remède

Indonesian cinnamon (Cinnamomum burmanii) contains bioactive compounds, particularly cinnamaldehyde and procyanidins, that may improve insulin sensitivity and enhance glucose uptake in cells. These compounds appear to activate insulin receptor signaling pathways and may inhibit enzymes involved in carbohydrate metabolism. Evidence level C studies suggest potential hypoglycemic effects, though more rigorous clinical trials are needed to confirm mechanisms. The traditional Jamu use for diabetes management aligns with these proposed glucose-regulating properties.

Indonesian cinnamon may enhance the blood sugar-lowering effects of diabetes medications such as metformin, insulin, or sulfonylureas, potentially causing hypoglycemia. Evidence level C suggests additive hypoglycemic effects are possible. If you take antidiabetic medications, monitor blood glucose closely and consult your healthcare provider before adding cinnamon supplements. Additionally, cinnamon contains coumarin compounds that may interact with anticoagulant medications like warfarin, increasing bleeding risk.

The traditional Jamu dosage for Indonesian cinnamon bark is 1-6 grams of dried bark daily, typically prepared as a decoction, infusion, or powder. This dosage range is based on traditional use and limited clinical evidence (level C). For blood sugar management, starting at the lower end of 1-2 grams daily is advisable to assess individual tolerance. Higher doses should be approached cautiously due to potential coumarin-related liver concerns. Consult a qualified herbal practitioner for personalized dosing guidance.

Indonesian cinnamon is considered unsafe during pregnancy and should be avoided. The herb contains compounds that may stimulate uterine contractions, and the coumarin content poses potential risks to fetal development. Traditional contraindications explicitly list pregnancy as a precaution. Breastfeeding women should also avoid medicinal doses, though small culinary amounts in food are generally considered acceptable. Pregnant individuals should consult their healthcare provider before using any cinnamon supplements or concentrated extracts.

The primary safety concern with Indonesian cinnamon is liver toxicity from excessive coumarin intake, particularly with prolonged high-dose use or in individuals with pre-existing liver disease. Evidence level C supports this caution. Other potential side effects include allergic skin reactions, oral irritation from cinnamaldehyde contact, and hypoglycemia when combined with diabetes medications. Individuals with known coumarin sensitivity should avoid this herb entirely. Using moderate doses within the recommended range and periodic breaks from supplementation can help minimize adverse effects.